Mounjaro
Approved for type 2 diabetes. Prescribed off-label for weight very widely. The medicine is not in question; the approval is, and it does not match a weight-management diagnosis.
Getting a prescription
Mounjaro is tirzepatide approved for type 2 diabetes. It is not approved for weight loss, and prescribing it for that purpose is off-label — lawful, common, and the reason most weight-related claims against it are refused.
If weight management is the goal and there is no diabetes diagnosis, Zepbound is the same molecule with the matching approval. That is usually the product being looked for, whether or not it is the one being asked about.
What to know first
Identical to any tirzepatide prescription, with one conversation that is specific to this product and best had before money changes hands.
Height, weight, and history, including whether you carry a type 2 diabetes or prediabetes diagnosis. That answer determines whether this product is on-label for you and how a claim will be read.
If weight is the goal without a diabetes diagnosis, ask why Mounjaro rather than Zepbound. Supply is a legitimate answer; the question should still get a direct one.
Set them before the prescription is written. A plan covering Mounjaro for diabetes will commonly refuse it for weight, and the pharmacy counter is an expensive place to find out.
Mounjaro and Zepbound do not share a dosing schedule, so switching later is not a straight substitution. Ask what follow-up costs and how a switch would be handled.
One molecule, three positions. For weight care the difference is which one an insurer will read as appropriate.
Approved for type 2 diabetes. Prescribed off-label for weight very widely. The medicine is not in question; the approval is, and it does not match a weight-management diagnosis.
The same molecule approved for chronic weight management, and separately for obstructive sleep apnea. The product normally sought when weight is the goal.
Not an FDA-approved generic and not reviewed as a finished product. Common in cash-pay programs and outside any coverage pathway.
For how it works, its side effects, and how it compares with the alternatives, see the tirzepatide medication guide.
Brand cash pricing is high and the coverage that would offset it is exactly what the off-label question puts at risk. Only 92 of the 178 listings here publish a price.
A weight diagnosis on a Mounjaro prescription is the most common reason a claim is refused. Where a plan covers weight care it usually names the weight-indicated product.
With type 2 diabetes documented, Mounjaro is on-label and coverage becomes an ordinary formulary matter.
Availability by dose has moved repeatedly. A program quoting a price should say what happens in a month when your dose is not available.
Establish whether the monthly figure includes medication or only visits, and what the maintenance dose costs.
178 clinics we checked prescribe mounjaro, spread across 29 states.
Sources: FDA Zepbound prescribing information · NIDDK, Prescription Medications to Treat Overweight & Obesity. Eligibility and prescribing decisions belong to a qualified healthcare professional. This page is informational and is not medical advice.
More on mounjaro